Gregory H. Bailey - 15 Aug 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Gregory Bailey
Issuer symbol
SER
Transactions as of
15 Aug 2024
Net transactions value
+$140,116
Form type
4
Filing time
20 Aug 2024, 16:35:17 UTC
Previous filing
16 Aug 2024
Next filing
22 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SER Common Stock Purchase $42,577 +6,400 +24% $6.65 33,006 15 Aug 2024 Direct F1
transaction SER Common Stock Purchase $46,780 +6,400 +19% $7.31 39,406 16 Aug 2024 Direct F2
transaction SER Common Stock Purchase $50,760 +6,400 +16% $7.93 45,806 19 Aug 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F2 The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
F3 The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.